Age peaks of different RDC/TMD diagnoses in a patient population

Manfredini, Daniele; Piccotti, Fabio; Ferronato, Giuseppe; Guarda-Nardini, Luca

doi:10.1016/j.jdent.2010.01.006

Cited by 181 publications

(141 citation statements)

References 7 publications

Supporting

Mentioning

102

Contrasting

Unclassified

Order By: Relevance

“…Similarly, in this study out of 60 subjects, 78.33% were <45 years of age. Manfredini et al [6] reported that disc displacements disorders occur around the age of 30 years and inflammatory-degenerative joint disorders over the age of 50 years which is in accordance with observations of this study where mean age for disc displacement disorders was 35 ± 3.99 years and 51.5 ± 0.44 years for inflammatory and degenerative disorders.…”

Section: Discussionsupporting

confidence: 92%

Phonophoresis in temporomandibular joint disorders: A clinical trial

Vijayalakshmi¹,

Mubeen²,

Rajguru³

2015

JCRI

View full text Add to dashboard Cite

Background and Objective: Temporomandibular joint disorders (TMDs) are identified as a major cause of non-dental pain in the orofacial region. An effective drug delivery into this complex joint can result in a good prognosis. Phonophoresis is a novel phenomenon that exponentially increases the absorption of topical pharmacological compounds and achieves effective therapeutic drug concentration at the target site. Hence, this study is designed to assess the feasibility and effectiveness of aceclofenac gel phonophoresis in the management of TMDs. Methods: Selected 60 patients were randomly divided into two equal groups. Group A were treated with aceclofenac gel phonophoresis and Group B with that of its topical application for 15 days. The scores of visual analog scale (VAS), maximum mouth opening, lateral and protrusive excursion, Helkimo anamnestic and clinical dysfunction index, erythrocyte sedimentation rate, and C-reactive protein were evaluated at baseline and 15 days after treatment. Results: Statistically significant increase in mean maximum mouth opening, lateral excursion and a significant reduction in scores of VAS, Helkimo anamnestic, and clinical dysfunction index were observed post-treatment in Group A as compared to Group B. Conclusions: Aceclofenac gel phonophoresis is feasible and effective in reduction of signs and symptoms of TMDs.

show abstract

Section: Discussionsupporting

confidence: 92%

Phonophoresis in temporomandibular joint disorders: A clinical trial

Vijayalakshmi¹,

Mubeen²,

Rajguru³

2015

JCRI

View full text Add to dashboard Cite

show abstract

“…Manfredini et al identified at least two distinct age peaks within a patient population: one at about age 30 to 35 years, with disk displacement, and another at about age 50 to 55 years, with arthritis and/or arthrosis (17). Guarda-Nardini et al identified two age peaks in TMD prevalence: one at around age 52 years for patients with joint crepitus from degenerative disease and another at around age 38 years for patients without joint crepitus (18).…”

Section: Discussionmentioning

confidence: 99%

Age-related associations between psychological characteristics and pain intensity among Japanese patients with temporomandibular disorder

et al. 2014

View full text Add to dashboard Cite

We investigated the relationship between pain intensity and psychosocial characteristics in patients with temporomandibular disorder (TMD).Participants with painful TMD, according to the Research Diagnostic Criteria for TMD (RDC/TMD), were recruited from our clinic and classified into six age groups: 15 to 24, 25 to 34, 35 to 44, 45 to 54, 55 to 64, and 65 to 85 years (Groups A through F, respectively). Self-reported present pain intensity and worst pain intensity during the past 6 months were ascertained using a numeric rating scale (0 to 10). Depression and somatization scores were evaluated using the RDC/ TMD axis II questionnaire. Among women, worst pain intensity was significantly lower in Groups E and F than in Groups B and C (P < 0.05). In Groups A, C, and D, depression scores were significantly higher in women than in men (P < 0.05). Among women, depression score was significantly lower in Group F than in Groups A through C (P < 0.05). In Groups A through D, somatization scores were significantly higher for women than for men (P < 0.05). Depression score and TMD symptom severity appear to decrease with age in women. (J Oral Sci 56, 221-225, 2014)

show abstract

“…Women have higher values than men, this difference may be due to behavioral, hormonal, anatomical, and psychological factors. 8,11,12 Significant differences in age do not occur in cases of myofascial pain and disc displacement, average age of the sufferer was 27 years 2 and lubrication and nutrition due to biomechanical disorders. 13 In this study, there were significant differences in MMP-9 levels between disc displacement and myofascial pain patients.…”

Section: Discussionmentioning

confidence: 99%

The difference of matrix metalloproteinase-9 level in saliva between myofascial pain and disc displacement of temporomandibular joint disorders

Rafni¹,

Yanwirasti

Darwin

et al. 2017

Padjadjaran J Dent

View full text Add to dashboard Cite

Introduction: Saliva is the type of liquid which contains enzyme, hormone, antibody, constituent microbe, and cytokines. Matrix metalloproteinase-9 (MMP-9) is one kind of proteolysis cellular enzyme in saliva that has a role in inflammation. Saliva is very easy to take and noninvasive treatment, proved efficient for early diagnosis. The purpose of this research was to study the difference MMP-9 level in saliva patient with temporomandibular joint disorders between myofascial pain and disc displacement. Methods: Cross sectional comparative study. The research was carried out at the Prosthodontics Clinic of Arifin Achmad Pekanbaru Hospital and at Biomedical Laboratory of Faculty of Medicine, Universitas Andalas Padang, Indonesia. The saliva samples were taken from 37 myofascial pain patients and 37 disc displacement patients. MMP-9 levels were examined by the Elisa and the data result was analyzed using the t-test. Result: The average value of MMP-9 level of disc displacement was 650.98±384.94 pg/mL and myofascial pain was 168.70±41.24 pg/mL. There was a significant difference on MMP-9 level in saliva between myofascial pain and disc displacement (p<0.05). Conclusion: The MMP-9 level in saliva of patients with disc displacement of temporomandibular joint disorders was higher than patients with myofascial pain.

show abstract

Age peaks of different RDC/TMD diagnoses in a patient population

Cited by 181 publications

References 7 publications

Phonophoresis in temporomandibular joint disorders: A clinical trial

Phonophoresis in temporomandibular joint disorders: A clinical trial

Age-related associations between psychological characteristics and pain intensity among Japanese patients with temporomandibular disorder

The difference of matrix metalloproteinase-9 level in saliva between myofascial pain and disc displacement of temporomandibular joint disorders

Contact Info

Product

Resources

About